Related Experiment Videos
Using estimated yearly progression rates to compare radiographic data across recent randomised controlled trials in
V Strand1, R Landéwé, D van der Heijde
1Stanford University, Division of Immunology, Palo Alto, CA, USA. vstrand@aol.com
Annals of the Rheumatic Diseases
|October 16, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Performance of cut-offs of the ASAS Health Index to discriminate between treatment groups in patients with axial spondyloarthritis in the TICOSPA trial.
Seminars in arthritis and rheumatism·2024
The ASAS-OMERACT core domain set for axial spondyloarthritis.
Seminars in arthritis and rheumatism·2021
Impact of disease activity on bone density, microarchitecture, and biomechanical properties in rheumatoid and psoriatic arthritis over 7 years.
Annals of the rheumatic diseases·2026
Interferon-stimulated gene signature predicts clinical response to low-dose IL-2 in immune-mediated inflammatory diseases.
Annals of the rheumatic diseases·2026
Low-dose blinatumomab in multidrug-resistant rheumatoid arthritis-a case series.
Annals of the rheumatic diseases·2026
Spatially distinct macrophage subsets drive myofibroblast heterogeneity and maladaptive fibrosis in lupus nephritis.
Annals of the rheumatic diseases·2026
Longitudinal computed tomography body composition changes in patients receiving curative radiotherapy for non-small cell lung cancer.
Physics and imaging in radiation oncology·2026
VMAT-based lattice radiotherapy for advanced bulky hepatocellular carcinoma within multimodality treatment: a consecutive feasibility series.
Clinical and translational radiation oncology·2026